CNBC   |  March 25, 2013

Mixed Session For Generic Drugmakers

CNBC's Seema Mody reports the latest from the Nasdaq: Drug makers Actavis and Astrazeneca reach an agreement to launch a Crestor generic in 2016.

Share This:

Sorry, we do not have a transcript available for this video at this time.